Sivashangar Ahalyaa, Wimalachandra Manujasri, Meegoda Jithmal, Perera Thisarika, Karunanayake Panduka, Arya Roopen, Gooneratne Lallindra
Department of Pathology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
IJID Reg. 2025 Feb 12;15:100598. doi: 10.1016/j.ijregi.2025.100598. eCollection 2025 Jun.
Dengue is a global health concern. Early identification of patients whose disease is likely to progress to a critical phase helps reduce mortality.
A total of 136 patients with fever, a positive dengue NS1 antigen test result, a platelet count >100 × 10/l, and no plasma leakage who were admitted to National Hospital, Sri Lanka had conventional coagulation tests (CCTs); prothrombin time, activated partial thromboplastin time (APTT) and Clauss fibrinogen and ROTEM (rotational thromboelastometry) tests; extrinsic coagulation pathway (EXTEM) and intrinsic coagulation pathway (INTEM) on ROTEM performed on the 3 day of fever. Patients were followed up and categorized as "cases" if they progressed to critical phase and "controls" if they did not.
A total of 36 cases and 100 controls were recruited. Results of the CCTs were not significant. The three ROTEM parameters (clotting time and clot formation time of the EXTEM and clot formation time of INTEM) had cut-off values with acceptable sensitivities and specificities on receiver operating characteristic curve analysis. When combined, these parameters predicted patients whose disease was unlikely to progress to a critical phase (negative predictive value of 84.37%).
ROTEM parameters on the 3 day of fever predicted progression, whereas CCTs did not. These parameters were generated in approximately 10 minutes, at the point of care. It would be prudent to substantiate these findings in a larger study. The subclinical coagulopathy evidenced by derangements in ROTEM with normal Clauss and platelet >100 × 10/l raises the possibility of platelet dysfunction being the cause.
登革热是一个全球关注的健康问题。早期识别疾病可能进展至重症阶段的患者有助于降低死亡率。
共有136名发热、登革热非结构蛋白1(NS1)抗原检测结果呈阳性、血小板计数>100×10⁹/L且无血浆渗漏的患者入住斯里兰卡国立医院,在发热第3天进行了常规凝血试验(CCT);凝血酶原时间、活化部分凝血活酶时间(APTT)、Clauss纤维蛋白原检测以及旋转血栓弹力图(ROTEM)检测;ROTEM的外源性凝血途径(EXTEM)和内源性凝血途径(INTEM)检测。对患者进行随访,若进展至重症阶段则归类为“病例组”,未进展则归类为“对照组”。
共招募了36例病例组和100例对照组。CCT结果无显著差异。在接受者操作特征曲线分析中,ROTEM的三个参数(EXTEM的凝血时间和凝块形成时间以及INTEM的凝块形成时间)具有可接受的敏感性和特异性的临界值。综合这些参数可预测疾病不太可能进展至重症阶段的患者(阴性预测值为84.37%)。
发热第3天的ROTEM参数可预测病情进展,而CCT则不能。这些参数在床旁约10分钟内即可得出。在更大规模的研究中证实这些发现将是谨慎之举。ROTEM异常而Clauss正常且血小板>100×10⁹/L所证明的亚临床凝血病增加了血小板功能障碍作为病因的可能性。